首页> 外文期刊>Annals of Medicine and Surgery >Plasma d-dimer level correlated with advanced breast carcinoma in female patients
【24h】

Plasma d-dimer level correlated with advanced breast carcinoma in female patients

机译:女性患者血浆d-二聚体水平与晚期乳腺癌相关

获取原文
           

摘要

BackgroundAdvanced breast cancer is a common disease among female in the world. There is a correlation between cancer and hyper coagulation. In a cancer state, there is an increase in the level of cross-linked fibrin degradation product (d-dimer)which indicates systemic activation of fibrinolysis and hemostasis. So, there is a relation between increase d-dimer value and advanced breast disease.ObjectiveTo confirm the relation between increase d-dimer levels and advanced breast carcinoma in female patients.Patients and methodsA prospective study (cohort study) done in Baghdad teaching hospital (department of surgery) from Jan 2014 to Jan 2016. Seventy patients were categorized intotwo equal groups, group 1 with breast carcinoma, group 2 with benign breast tumor. Plasma d-dimer levels compared for each group, and in relation to (tumor size, stage, grade, lympho-vascular invasion, and lymph nodes involvement).ResultsD-dimer level was normal in group two (<0.25) mg/l and high in group one in other words, d-dimer level was increasing in advanced breast carcinoma group with enlarge tumor size, high stage, grade, lympho-vascular invasion and lymph nodes involvement.ConclusionsPlasma d-dimer levels was good prognostic factor in breast carcinoma specially in advanced breast carcinoma and its considered factor clinical stage progression lympho-vascular invasion and metastasis.
机译:背景技术晚期乳腺癌是世界上女性普遍的疾病。癌症与高凝之间存在相关性。在癌症状态下,交联的纤维蛋白降解产物(d-二聚体)水平增加,这表明纤维蛋白溶解和止血的系统性激活。因此,d-二聚体值的升高与晚期乳腺疾病之间存在联系。目的确定女性患者中d-二聚体水平升高与晚期乳腺癌之间的关系。患者和方法在巴格达教学医院进行的前瞻性研究(队列研究) 2014年1月至2016年1月。将70例患者分为两组,第一组为乳腺癌,第二组为良性乳腺肿瘤。比较各组血浆d-二聚体水平,并与(肿瘤大小,分期,等级,淋巴管浸润和淋巴结受累)相关。结果第二组D-二聚体水平正常(<0.25)mg / l,换句话说,血浆D-二聚体水平是乳腺癌的良好预后因素,晚期乳腺癌组的D-二聚体水平升高,且肿瘤大小增大,分期,分级,淋巴管浸润和淋巴结受累。结论特别是在晚期乳腺癌及其考虑因素临床分期进展中,淋巴管浸润和转移。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号